Covance Launches External Laboratory-Management Services
Covance launches external laboratory-management services for clinical trials.
The CRO Covance has launched external laboratory-management services, a new offering that provides biopharmaceutical companies with management solutions for external laboratory testing associated with clinical trials. Covance’s external laboratory management services are designed to increase the quality of clinical- study data by managing specialty laboratory testing for clients along with services provided by a central laboratory. These services include laboratory selection and qualification, auditing, vendor management, contracting, and data cleaning. The new services will be managed by a team within Covance's central laboratory services and expands Covance's capabilities in central laboratory testing, biosample management, and data services.
Source: Covance
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.
